Insider Cluster (3 insiders) ·Filed Jul 7, 2026

QURE

uniQure N.V.
BEARISH
Impact 5/10
Horizonweeks Processed2mo ago
Insider cluster: 3 insiders, $1.7M total
Actionable Insight ▼ Bearish

Insider sales are small relative to market cap but the timing—within days of a $225M discount offering—indicates insiders were comfortable selling after dilution. Watch for additional selling by C-suite and potential follow-on offerings. The CEO's option exercise also adds selling pressure.

DirectionBearish
Confidencemedium
Horizonweeks
Latest settled — T+20d
QURE ▲ +6.40% at T+20d
SHORT call ✗ call lost -6.40% · α vs SPY -5.07% · entry $41.41 → $44.06
Next anchor: T+60d due 3d ago
Latest observation: T+57 +75.27% FF3 residual α
Entry anchored
Jul 6, 03:59 PM ET
via exchange tick
T+1d
+5.02%
call -5.02% · α -5.33%
$43.49
settled 3mo ago
T+5d
+0.27%
call -0.27% · α +0.29%
$41.52
settled 3mo ago
T+20d
+6.40%
call -6.40% · α -5.07%
$44.06
settled 2mo ago
T+60d
—
call — · α —
—
due 3d ago

Price Chart

Loading chart...

Executive Summary

Three insiders at uniQure (QURE), including the CEO and Chief Medical Officer, sold a combined $1.67M in stock within a week of a $225M dilutive offering. CEO Kapusta also exercised options in a cashless transaction. The cluster is small relative to the $2.6B market cap (~0.06%) but carries negative signal due to its proximity to the capital raise, which was priced at a 7.2% discount to market.

Key Financial Metrics

Direction
selling
Total Value
$1.7M
Insiders
3

Key Facts

  • Three insiders sold a total of $1.67M in QURE stock over 7 days (ending 2026-07-02).
  • CEO Matthew Kapusta sold $953K (net of option exercise) across three open-market trades on the same day (2026-07-02).
  • Director Jack Kaye sold $792K on 2026-06-30.
  • Chief Medical Officer Walid Abi-Saab sold $465K on 2026-06-30.
  • The stock offering (424B5) priced 4.95M new shares at $45.50 on 2026-06-23, a 7.2% discount to the prior close.
  • Total insider sales represent ~0.06% of QURE's $2.6B market cap—below the 0.1% materiality threshold.
  • No 10b5-1 plans were disclosed for these sales.

Financial Impact

Insider sales of $1.67M, or ~0.06% of market cap, executed after a $225M dilutive offering at a discount.

insider confidence signaldilution overhang

Risk Factors

  • Additional insider selling from recently vested shares
  • Near-term equity overhang from the 7.8% dilution in the June 2026 offering
  • Sentiment overhang from insiders selling after a capital raise

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
76% bullish (21 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-QURE-1783490792917
32 reports for QURE
Performance horizon
75% Hit rate 6 of 8 directional calls best @ T+20▲ +27.15%Jul 29, 2026
Filters
Rows
Reports for QURE — sortable, filterable
TypeNow
Sep 2, 2026
4w ago
8-K
BULLISH ★ 7/10
$46.23 $44.47▼ −3.81%▼ −2.85%$23.46 (−49.25%)
Jul 29, 2026
9w ago
8-K
BULLISH ★ 8/10
$40.07 $44.24▲ +10.41%▲ +4.88%$23.46 (−41.45%)
Jul 7, 2026
12w ago
Insider Cluster
BEARISH ★ 5/10
$41.41 $41.52▼ −0.27%▲ +0.29%$23.46 (+43.35%)
Jul 2, 2026
13w ago
Insider Cluster
BEARISH ★ 4/10
$41.81 $44.48▼ −6.39%▼ −5.46%$23.46 (+43.89%)
Jul 2, 2026
13w ago
Insider Cluster
MIXED ★ 5/10
$41.81 $44.48▲ +6.39%▲ +5.46%$23.46 (−43.89%)
Jul 2, 2026
13w ago
144
NEUTRAL ★ 2/10
$41.81 $44.48▲ +6.39%▲ +5.46%$23.46 (−43.89%)
Jun 30, 2026
13w ago
144
NEUTRAL ★ 2/10
$45.17 $41.41▼ −8.32%▼ −8.59%$23.46 (−48.06%)
Jun 25, 2026
14w ago
144
BEARISH ★ 5/10
$47.51 $41.81▲ +12.00%▲ +14.16%$23.46 (+50.62%)
Jun 24, 2026
14w ago
424B5
MIXED ★ 6/10
$49.10 $45.17▼ −8.00%▼ −9.56%$23.46 (−52.22%)
Jun 24, 2026
14w ago
144
NEUTRAL ★ 2/10
$49.10 $45.17▼ −8.00%▼ −9.56%$23.46 (−52.22%)
Showing 10 of 32

US Market Status

Market Closed — Opens Mon (65h 4m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Jul 8, 2026